Acute and transient inflammation may inhibit tumor growth (Fan et al., 2020) by upregulating pro-inflammatory cytokines such as TNFα, IL-1β, and IL-6 that are part of the initial inflammatory cascade and recruit other downstream targets to enhance anti-tumor responses. This evidence concerns the gene IL6 and neoplasm.